Peakdale's Director of Technology Paul Doyle said: "This represents an exciting new technology that allows a much broader base of researchers to access the world of diverse compounds in a cost effective manner."
Adding to this, ChemPrintCo's Vice President of Sales Ron Jones said: "The AssayReady4U(TM) products will be offered via an innovative web-based one-stop shopping storefront. The researchers will effortlessly select compounds, assay test concentration, plate format, plate manufacturer and controls with a few clicks of a mouse thus optimizing their valuable time for research."
About Peakdale Molecular
Peakdale Molecular was founded in 1992. Today the company's customers include the majority of the major global pharmaceutical businesses and a rapidly growing base of biotechnology companies worldwide. Peakdale's teams of chemists combine experience in pharmaceutical R&D, medicinal chemistry, parallel synthesis, process development and fine chemicals to deliver unique chemistry solutions to a range of drug discovery challenges. Peakdale has growing capabilities in computational chemistry, analytical chemistry and ADME screening.
The application of less commonly used chemistry, including high temperature/pressure reactions, proprietary heterocyclic chemistry and nucleoside synthesis, enables Peakdale's chemists to generate unique compounds for drug discovery. Peakdale operates in several distinct markets providing novel screening compounds, targeted screening libraries, catalogue intermediates, custom synthesis and contract research. Further information about the company can be obtained at http://www.peakdale.com
About ChemPrintCo LLC
ChemPrintCo is a privately held company located in the heart of Silicon
Valley and the Bay Area's deep biotech and pharmaceutical community. The
|SOURCE Peakdale Molecular Ltd and ChemPrintCo LLC|
Copyright©2008 PR Newswire.
All rights reserved